Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015
Author(s) -
Grace D. Appiah,
Sandra S. Chaves,
Pam Daily Kirley,
Lisa A. Miller,
James Meek,
Evan J. Anderson,
Oluwakemi Oni,
Patricia Ryan,
Seth Eckel,
Ruth Lynfield,
Marisa Bargsten,
Shelley M. Zansky,
Nancy M. Bennett,
Krista Lung,
Christie McDonald-Hamm,
Ann Thomas,
Diane Brady,
Mary Lou Lindegren,
William Schaffner,
Mary Hill,
Shikha Garg,
Alicia M. Fry,
Angela P. Campbell
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw745
Subject(s) - medicine , antiviral treatment , pandemic , pandemic influenza , covid-19 , population , antiviral therapy , pediatrics , influenza a virus , h1n1 pandemic , virology , virus , infectious disease (medical specialty) , environmental health , disease , chronic hepatitis
(See the Editorial Commentary by Martin on pages 368-9.)Using population-based surveillance data, we analyzed antiviral treatment among hospitalized patients with laboratory-confirmed influenza. Treatment increased after the influenza A(H1N1) 2009 pandemic from 72% in 2010-2011 to 89% in 2014-2015 (P < .001). Overall, treatment was higher in adults (86%) than in children (72%); only 56% of cases received antivirals on the day of admission.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom